Literature DB >> 9445402

Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.

L Isaac1, D Aivazian, A Taniguchi-Sidle, R O Ebanks, C S Farah, M P Florido, M K Pangburn, D E Isenman.   

Abstract

The thioester bond in complement components C3 and C4 and the protease inhibitor alpha2-macroglobulin have traditionally been thought of as fulfilling the dual roles of mediating covalent attachment and maintaining the native conformational states of these molecules. We previously reported that several human C3 thioester-region mutants, including variants E1012Q and C1010A, in the latter of which thioester-bond formation is precluded, display an unexpected phenotype. Despite the lack of a thioester bond in these mutants, they appear to adopt a native-like conformation as suggested by the finding that they are cleavable by the classical pathway C3 convertase, C4b2a, whereas the C3b-like C3(H2O) species is not. Subsequently, a species referred to as C3(NH3)* was described which potentially could account for the observations with the above mutants. C3(NH3)* is a transient species formed on aminolysis of native C3 that can spontaneously re-form the thioester bond. Importantly, it has a mobility on cation-exchange HPLC that is distinct from both native C3 and C3(H2O), but like the native molecule, it is cleavable by an alternative-pathway C3 convertase. In this study we showed by using cation-exchange HPLC as an additional conformational probe that C3 C1010A and E1012Q mutant proteins did not resemble C3(NH3)*. Instead they displayed a chromatographic behaviour that was indistinguishable from that of native C3. To assess the general applicability of these observations, we engineered the equivalent mutations into human C4, specifically C4 C1010A and C4 E1012Q. As expected, thioester-bond formation did not occur in either of these C4 mutants, but in contrast with the results with C3 we found no evidence for the formation of a stable native-like conformation in either C4 mutant, as assessed using cleavability by C1s as the conformational probe. A possible interpretation of our data is that the adoption of the native conformational state during biosynthesis of C3 and C4 is an energetically permissible process, even if it is not locked in via thioester-bond formation. Whereas this conformational state is stable in mature C3, it is unstable in mature C4, perhaps reflecting the additional post-translational cleavage of C4 before its secretion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9445402      PMCID: PMC1219096          DOI: 10.1042/bj3290705

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Structural requirements for thioester bond formation in human complement component C3. Reassessment of the role of thioester bond integrity on the conformation of C3.

Authors:  L Isaac; D E Isenman
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

2.  A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.

Authors:  R O Ebanks; A S Jaikaran; M C Carroll; M J Anderson; R D Campbell; D E Isenman
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

Review 3.  alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation.

Authors:  C T Chu; S V Pizzo
Journal:  Lab Invest       Date:  1994-12       Impact factor: 5.662

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines.

Authors:  F Van Leuven; J J Cassiman; H Van Den Berghe
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

6.  Third component of human complement: structural requirements for its function.

Authors:  J Janatova; B F Tack; J W Prahl
Journal:  Biochemistry       Date:  1980-09-16       Impact factor: 3.162

7.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

8.  Thiol ester role in correct folding and conformation of human alpha 2-macroglobulin. Properties of recombinant C949S variant.

Authors:  P G Gettins; E Boel; B C Crews
Journal:  FEBS Lett       Date:  1994-02-21       Impact factor: 4.124

9.  Amino acid sequence of hen ovomacroglobulin (ovostatin) deduced from cloned cDNA.

Authors:  K L Nielsen; L Sottrup-Jensen; H Nagase; H C Thøgersen; M Etzerodt
Journal:  DNA Seq       Date:  1994

10.  Synthesis of a Cys949Tyr alpha 2-macroglobulin thiol ester mutant: co-transfection with wild-type alpha 2-macroglobulin in an episomal expression system.

Authors:  L Van Rompaey; H Van den Berghe; P Marynen
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

View more
  5 in total

1.  Homozygous hereditary C3 deficiency due to a premature stop codon.

Authors:  Edimara Da Silva Reis; Gisele Vanessa Baracho; Adriana Sousa Lima; Chuck S Farah; Lourdes Isaac
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.

Authors:  Chih-Feng Kuo; Yee-Shin Lin; Woei-Jer Chuang; Jiunn-Jong Wu; Nina Tsao
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

3.  Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.

Authors:  Tiehui Wang; Christopher J Secombes
Journal:  Immunogenetics       Date:  2003-11-20       Impact factor: 2.846

4.  Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease.

Authors:  Michelle Elvington; M Kathryn Liszewski; Alexis R Liszewski; Hrishikesh S Kulkarni; Ramsey R Hachem; Thalachallour Mohanakumar; Alfred H J Kim; John P Atkinson
Journal:  Front Immunol       Date:  2019-04-04       Impact factor: 7.561

5.  Structure of Complement C3(H2O) Revealed By Quantitative Cross-Linking/Mass Spectrometry And Modeling.

Authors:  Zhuo A Chen; Riccardo Pellarin; Lutz Fischer; Andrej Sali; Michael Nilges; Paul N Barlow; Juri Rappsilber
Journal:  Mol Cell Proteomics       Date:  2016-06-01       Impact factor: 5.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.